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Abstract
Background: Compared to those in higher socioeconomic groups, diabetic patients in lower socioeconomic
groups have less favourable metabolic control and experience more diabetes-related complications. They
encounter specific barriers that hinder optimal diabetes self-management, including a lack of social support and
other psychosocial mechanisms in their immediate social environments. Powerful Together with Diabetes is a
culturally sensitive social network intervention specifically targeted to ethnic Dutch, Moroccan, Turkish, and
Surinamese diabetic patients in lower socioeconomic groups. For ten months, patients will participate in peer
support groups in which they will share experiences, support each other in maintaining healthy lifestyles, and learn
skills to resist social pressure. At the same time, their significant others will also receive an intervention, aimed at
maximizing support for and minimizing the negative social influences on diabetes self-management. This study
aims to test the effectiveness of Powerful Together with Diabetes.
Methods/Design: We will use a quasi-experimental design with an intervention group (Group 1) and two
comparison groups (Groups 2 and 3), N = 128 in each group. Group 1 will receive Powerful Together with Diabetes.
Group 2 will receive Know your Sugar, a six-week group intervention that does not focus on the participants’ social
environments. Group 3 receives standard care only. Participants in Groups 1 and 2 will be interviewed and
physically examined at baseline, 3, 10, and 16 months. We will compare their haemoglobin A1C levels with the
haemoglobin A1C levels of Group 3. Main outcome measures are haemoglobin A1C, diabetes-related quality of life,
diabetes self-management, health-related, and intermediate outcome measures. We will conduct a process
evaluation and a qualitative study to gain more insights into the intervention fidelity, feasibility, and changes in the
psychosocial mechanism in the participants’ immediate social environments.
Discussion: With this study, we will assess the feasibility and effectiveness of a culturally sensitive social network
intervention for lower socioeconomic groups. Furthermore, we will study how to enable these patients to
optimally manage their diabetes. This trial is registered in the Dutch Trial Register: NTR1886
Keywords: Type 2 diabetes, Lower socioeconomic groups, Turkish, Moroccan, Surinamese patients, Social network
intervention, Diabetes self-management
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Background
Lower socioeconomic (SE) groups are not only dispro-
portionately affected by type 2 diabetes, they also have
more diabetes-related complications and higher dia-
betes-related mortality compared to diabetic patients in
higher SE groups [1-3]. A possible explanation for this
could be poorer glycaemic control. Achieving optimal
glycaemic control requires the diabetic patient to take
part in a complex set of tasks: adhere to dietary advice
and medications, engage in regular physical activity, quit
smoking, and monitor blood glucose levels, known as
diabetes self-management (DSM) [4]. These tasks seem
to be more challenging for diabetic patients in lower SE
groups [5-7].
Interventions aimed at improving DSM can contribute
to better glycaemic control and the prevention of dia-
betes-related complications [8,9]. However, there are
indications that interventions for the general diabetic
population are less suitable for lower SE groups and
need to be adapted to the specific barriers they face
[10,11]. Barriers to DSM among lower SE groups
include a lack of knowledge of diabetes, low self-efficacy,
low perceived control, and low health literacy [5,7,12].
Another mentioned barrier to DSM among lower SE
groups is a lack of diabetes-related social support
[13-15]. To maintain lifestyle changes, long-term social
support in particular seems beneficial [13,16]. From
other fields such as sociology we know that social sup-
port is not the only psychosocial mechanism through
which the immediate social environment influences
health [17-19]. Other psychosocial mechanisms are
social influence such as peer pressure, norms and social
comparison processes, which extend from the social net-
work’s values and norms, and social engagement which
defines and reinforces meaningful social roles through
network participation [20]. These psychosocial mechan-
isms may have both negative and positive effects on
health behaviour [17]. For example, if the social norms
in the immediate social environment are incongruent
with DSM, family and/or friends might hinder DSM
(intentionally or unintentionally) by providing negative
role models or by exerting peer pressure [17,20,21].
Patients in lower SE groups are often surrounded by
social networks that seem to have a strong adverse effect
on their DSM. These groups often have small, dense
social networks with strong ties that consist primarily of
people in similar (low SE) situations to their own,
mainly family members and close friends [18]. Their
social networks often lack more distant acquaintances,
that is, people who move in different circles than their
own. These distant acquaintances are needed to intro-
duce resources, information, and ideas that might be
missing from their own social networks (such as dia-
betes related information and role models). These
‘closed’ social networks are known to impose strong
group norms on their social network members [18,20].
Combined with the unfavourable diabetes outcomes
among lower SE groups, this may suggest that these
groups are confronted with strong psychosocial mechan-
isms (social support, social influence and social engage-
ment) in their immediate social environments that
adversely affect their DSM. This is supported by recent
studies which show that lower SE groups experience dif-
ficulties in coping effectively with psychosocial mechan-
isms such as peer pressure, cultural expectations, fewer
positive role models, and not having control over their
family’s lifestyle choices [22-24].
To improve DSM among lower SE groups, it seems
important to focus specifically on creating long-term
diabetes-related social support, and to target the other
existing psychosocial mechanisms such as social influ-
ence and social engagement in their immediate social
environments that have adverse effects on their DSM.
Therefore, we systematically developed a theory-based
culturally sensitive social network intervention targeted
to ethnic Dutch, Turkish, Moroccan, and Surinamese
diabetic patients in lower SE groups. Powerful Together
with Diabetes (PTWD) aims to improve DSM by stimu-
lating long-term social support and targeting existing
psychosocial mechanisms in the immediate social envir-
onment that have an adverse effect on DSM. This paper
describes the intervention, the theoretical background of
this intervention, and the study design.
Methods/Design
The intervention: Powerful Together with Diabetes (PTWD)
To develop PTWD, we used the intervention mapping
method: a systematic approach for designing and evalu-
ating health-promotion interventions. The first step in
intervention mapping is a needs assessment, followed by
creating matrices of change objectives, selecting theory-
informed intervention methods and practical strategies,
and finally, producing programme components and
materials [25].
For the needs assessment, we examined the existing
literature for barriers to DSM among lower SE groups.
We also held semi-structured qualitative interviews with
diabetic patients (n = 21), analysed the content of an
internet forum for diabetic patients, and observed the
daily practices of a diabetic nurse in a neighbourhood
with low socioeconomic status for two days. We created
matrices of change objectives with the help of research-
ers specialized in intervention mapping. When selecting
theory-informed intervention methods and practical
strategies and producing programme components and
materials, we examined the existing literature and cur-
rently ongoing lifestyle interventions for methods and
strategies that would fit our target population. We also
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submitted our practical strategies and programme com-
ponents twice to a panel of experts with Turkish, Mor-
occan, and Surinamese backgrounds (n = 6), and
consulted them individually with specific questions
about the different cultural groups in our target popula-
tion. Finally, we pretested some of our intervention
components among the target population using focus
group discussions (n = 3).
Because this intervention has to stimulate long-term
social support and target existing psychosocial mechan-
isms in DSM, PTWD will consist of the following three
components: 1) group meetings for diabetic patients, 2)
group meetings for the participants’ significant others (e.
g. family and/or friends), and 3) social network therapy
sessions with the diabetic patient and his/her significant
other(s). PTWD will last ten months and consist of two
phases (see Table 1).
The intervention will be held in the mother tongue of
the participants. We culturally targeted PTWD by chan-
ging the outline of the intervention to make it compati-
ble with the ethnic minority participants’ annual visits
to their countries of origin and the celebration of Rama-
dan. We also culturally tailored the content of the inter-
vention components to the different cultural groups, for
example, by incorporating sociocultural values and bar-
riers to DSM, and adapting the materials to fit the
needs of the different cultural groups.
We describe the intervention components below,
including their behavioural goals and the determinants
we addressed to achieve these goals. The behavioural
goals were based on the theory of self-regulation, differ-
ent self-management theories, and the transactional
model of stress and coping, relapse prevention, and
social learning theories [26-30]. Because targeting psy-
chosocial mechanisms within the immediate social
environment of the participants (such as the exchange
of social support) plays an important part in this inter-
vention, for every intervention component we also cre-
ated separate behavioural goals for these determinants.
Group meetings for diabetic patients
The diabetic patients will participate in group meetings
(ten persons per group) for ten months. In Phase 1
(months 1-3), the participants will be provided with the
basic ‘tools’ they need to manage their diabetes. This
phase focuses on creating positive outcome expectations
[26,31] and moral norms [28,32], increasing knowledge,
skills [26], and self-efficacy [26,31], stimulating social
support [33], and recognizing and dealing with psycho-
social mechanisms that hinder optimal DSM, such as
peer pressure and existing social norms [20,31]. In
Phase 2 (months 4-10), the participants will learn how
to put the tools they gathered in Phase 1 to use. They
will develop and train DSM skills until they have a solid
set of coping skills [28,29,34], which will enable them to
optimally manage their diabetes in the long term.
To reach these behavioural goals and change the
determinants associated with them, we chose strategies
that would fit our target population and their specific
needs regarding information processing. For example, by
engaging the participants in an interactive diabetes quiz,
we aim to increase their practical knowledge about dia-
betes. We aim to increase DSM skills and self-efficacy
through a ‘letter of the week’, in which a fictitious dia-
betic patient presents a problem and asks the group
members for advice. To increase awareness about bar-
riers to DSM (Phase 2), the participants will monitor
their own behaviour with the help of specially designed
diaries. Through participatory problem-solving and
rehearsal situations, we aim to improve the participants’
skills and self-efficacy to overcome these barriers. Due
to the large number of behavioural goals, in Additional
files 1 and 2 we present a representative summary of
the behavioural goals, the determinants addressed, and
the strategies used in Phases 1 and 2.
Stimulating long-term social support and targeting
existing psychosocial mechanisms that have an adverse
effect on DSM are important parts of the intervention.
Examples of strategies used to stimulate social support
are interactive games in which the participants comple-
ment each other on their DSM and other subjects (self-
affirmation), and stimulating the exchange of advice
between participants. The participants are also encour-
aged to see each other outside of the group meetings,
and to undertake DSM-related activities together (e.g.
participating in an exercise initiative in the neighbour-
hood). A final aim of the intervention is that the partici-
pants will continue to see and consult each other after
the intervention has ended.
To stimulate social support and target existing psy-
chosocial mechanisms that have an adverse effect on
DSM in participants’ immediate social environments, we
use role-model stories, rehearsal situations, and home-
work assignments that focus on these behavioural goals.
In addition, the group meetings for the significant
others and the social network therapy sessions (see
Table 1 Overview of the two phases of Powerful Together
with Diabetes
Phase 1 (months 1-3) Phase 2 (months 4-10)
Thirteen weekly peer group
meetings for diabetic patients.
Three group meetings for
significant others.
Eight twice-monthly peer group
meetings for diabetic patients
followed by five monthly peer group
meetings.
Three group meetings for significant
others.
Two social network therapy sessions
for the diabetic patient and his/her
significant other(s).
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below) will contribute to the achievement of this beha-
vioural goal.
Group meetings for significant others
Each diabetic patient will identify one or two persons in
his/her immediate environment with a great deal of
influence on his/her DSM. These significant others will
participate in six group meetings with other significant
others: three during Phase 1 and three during Phase 2.
The diabetic patients will not be present during these
meetings.
In Phase 1, we will aim to increase the significant
others’ knowledge about diabetes and its treatment,
make them feel that DSM is necessary and inevitable
(outcome expectations and perceived cultural norms),
and that they have an important role in the DSM of
their relative/friend (perceived cultural norms and self-
efficacy). To increase the significant others’ knowledge,
we will use a short version of the interactive diabetes
quiz (which we use in the group meetings for the dia-
betic patients). Using positive role-model stories and
shared positive experiences from group members (vicar-
ious reinforcement) and group discussions, we will try
to increase positive outcome expectations and positive
moral norms towards DSM, and increase awareness
about the role of significant others in the DSM of dia-
betic patients.
In Phase 2, we will focus on supporting their relative/
friend in managing his/her diabetes. We will aim to
make the significant others aware of the fact that DSM
is a shared responsibility. Next, we will aim to make
them feel confident they can support the diabetic
patient with his/her DSM (self-efficacy) and be able to
effectively support the diabetic patient in his/her DSM
(skills). By exchanging positive experiences and through
communication skills training combined with rehearsal
situations and feedback, we will aim to improve the sig-
nificant others’ skills and self-efficacy (see Additional file
3). The group meetings will be followed by the social
network therapy sessions.
Social network therapy sessions
In Phase 2, the diabetic patient and his/her significant
other(s) will take part in two social network therapy ses-
sions. With these sessions, we will aim to further stimu-
late the exchange of social support and diminish
negative social influences on DSM. In these sessions, the
group leader will lead a discussion between the diabetic
patient and his/her significant other(s). In the first meet-
ing, they will discuss the ways the diabetic patient is
currently managing his/her diabetes and how his/her
DSM could be improved. Next, they will discuss the
ways the significant other(s) can assist the diabetic
patient in improving his/her DSM. Finally, they will
make an action plan to put the things discussed into
action. In the second meeting, this action plan will be
evaluated and further refined (see Additional file 4).
Intervention for the comparison group: Know your Sugar
To evaluate the effects of an extra focus on psychosocial
mechanisms and social support in the intervention
group, we chose to offer the comparison group a life-
style group intervention as well. Know your Sugar (KYS)
is a group intervention that aims to provide the partici-
pants with the information they need to be able to man-
age their diabetes, and provide them with the
opportunity to exchange social support. KYS will not
actively focus on social support and the pre-existing
psychosocial mechanisms that influence DSM in the
participants’ immediate social environments.
KYS consists of six weekly group meetings. It is based
on ‘How to deal with diabetes’, a Dutch course originally
developed for Turkish diabetic patients, and Dutch
National Institute for Health Promotion and Disease
Prevention (NIGZ) posters (i.e. large visual aids used by
diabetic nurses to facilitate explaining and talking about
diabetes-related subjects with patients). Both are known
as the current best practices in the Netherlands for dia-
betic patients in lower SE groups. Together they form
the foundation of KYS, which we then further developed
to make it culturally sensitive for the different cultural
groups in our study population. To increase the partici-
pants’ knowledge, we will use the same strategies we use
in PTWD, but with no extra focus on the exchange of
experiences and social support.
Training and supervision of group leaders
PTWD and KYS will be given by different group leaders.
The PTWD group leaders will receive a four-hour train-
ing prior to Phase 1 and a four-hour training prior to
Phase 2. The KYS group leaders will receive a two-hour
training prior to the intervention. During the interven-
tions, all group leaders will have regular contact with
the researchers by telephone. During these calls they
can ask questions about the intervention and get practi-
cal advice.
Research questions
This study will aim to answer the following research
questions:
1. What are the effects of the intervention (PTWD)
on haemoglobin A1C (HbA1c) compared with the
intervention for the comparison group (KYS) and
standard care at 3, 10, and 16 months?
2. What are the effects of the intervention on dia-
betes-related quality of life compared with the inter-
vention for the comparison group at 3, 10, and 16
months?
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3. What are the effects of the intervention on health-
related outcome measures, diabetes self-manage-
ment, and intermediate outcome measures compared
with the intervention for the comparison group at 3,
10, and 16 months?
4. What is the feasibility of the intervention and the
intervention for the comparison group?
5. What is the cost-effectiveness of the intervention
compared with the intervention for the comparison
group and standard care?
Study design
The intervention effects will be measured in a quasi-
experimental controlled trial: the DISC (Diabetes in
Social Context) Study. The participants who receive the
intervention (PTWD, N = 128) will be compared with
the participants of the comparison group (KYS, N =
128). In addition, the HbA1c levels of the participants in
both groups will be compared with the HbA1c levels of
128 diabetic patients who will receive no intervention at
all (standard care).
Matching, blinding, recruitment, and informed consent
For the intervention to be successful, it is important that
the participants live near each other. Therefore rando-
mization is impossible. Therefore, the intervention and
comparison group will be matched according to ethni-
city, gender, and organization of diabetes care. Blinding
the general practitioners (GPs) is impossible due to the
nature of this study.
Recruiting people and maintaining participation in
lower SE groups in intervention studies is difficult due
to a low level of trust and insufficient understanding of
the study and study procedures [35-38]. To increase
trust and understanding, the eligible patients will be
invited to a ‘welcome meeting’ about PTWD or KYS by
their GP, a person they trust and respect. For people
who do not speak Dutch, we will organize meetings in
their mother tongue. At the welcome meetings, the eli-
gible patients will receive detailed information about the
study procedures. They will also take part in one of the
intervention components (in PTWD groups, a short ver-
sion of the game about nutrition, in KYS groups a short
version of the diabetes quiz) to get an idea of what the
intervention will be like. They will also meet their group
leaders and the other patients and will see the interven-
tion location, which we hope will lower barriers to
participation.
At the end of the welcome meeting, the participants
have two weeks to consider their participation. After
two weeks they will be asked to sign an informed con-
sent form in which they agree to participate in the inter-
vention and give their consent for the study procedures.
The informed consent form will be read to the diabetic
patient and further explained if necessary. People who
do not speak Dutch will receive the information in their
mother tongue.
Ethical considerations
This study has been approved by the Medical Ethics
Committee of the Academic Medical Center (AMC) in
Amsterdam, and is registered with the Dutch Trial Reg-
ister (Dutch Trial Register NTR1886).
Study population
We will include people with type 2 diabetes who
received medical treatment long enough to achieve opti-
mal glycaemic control (one year) but still have a HbA1c
above 7% [39]. Inclusion criteria are at least one year
since diagnosis, HbA1c > 7%, > 35 years, and living in a
neighbourhood with low socioeconomic status. Exclu-
sion criteria are GP objection to participation, severe
psychiatric disorders, being unable to come to the inter-
vention location independently, and planning to stay
abroad for longer than six weeks during the intervention
period.
Taking into account the prevalence of type 2 diabetes
among ethnic minorities in lower SE groups in the
Netherlands, we expect half of the study population to
consist of ethnic Dutch patients and the other half to
come from minority groups, in particular patients with
Turkish, Moroccan, and Surinamese backgrounds.
Sample size calculation
The primary outcome measure is the decrease in HbA1c
at 16 months. A decrease of 0.5% in the intervention
group compared to the comparison group will be seen
as a difference that is clinically relevant. This means
that at a statistical significance of 5% and a power of
80%, we will need 92 participants in both the interven-
tion and the comparison group. Bearing in mind a drop-
out rate of 40%, we will need to include 128 people in
both the intervention group and the comparison group.
Measurements
Primary and secondary outcome measures
The primary outcome measures are the HbA1c levels of
the participants and diabetes-related quality of life at 16
months after the start of the intervention.
The secondary outcome measures are:
• Diabetes self-management (dietary habits, physical
activity, monitoring of blood glucose, medication
adherence, smoking, GP visits, body mass index (BMI))
• Health-related outcome measures (blood pressure,
heart rate, lipid profile, weight, waist and hip
circumference)
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Intermediate outcome measures are depression, atti-
tude, knowledge, self-efficacy, coping skills, size and
composition of participants’ social networks, social sup-
port, social influence, social engagement
Data collection (procedure of effect evaluation and process
evaluation)
Data collection will take place at baseline (T0), after 3
months (T1), after 10 months (T2), and after 16 months
(T3) for both the intervention group (PTWD) and the
comparison group (KYS). At T1 we will only administer
a short structured interview aimed to measure knowl-
edge and DSM. At T0, T2, and T3 we will administer a
structured interview and a physical examination. We
will study the participants’ medical records at all data
collection moments. The HbA1c levels of 128 patients
who receive standard care will be collected from a large
database owned by a GP collective in the Netherlands.
See Figure 1 for an overview of the measurements in
this study.
Structured interview
Data on diabetes-related behaviour and psychosocial and
intermediate outcome measures will be collected during
a structured interview, which will be conducted by a
trained interviewer. The questionnaire used in these
interviews will be translated and back-translated into
Turkish by two qualified independent translators and
discussed with the researchers. Rather than Arabic, we
expect the majority of our Moroccan participants to
speak Berber or Moroccan Arabic. Both are spoken lan-
guages only. Therefore, the questionnaire will be trans-
lated into Berber and Moroccan Arabic during
brainstorming sessions with three native speakers and
the researchers in which they will reach consensus
about the translation. The questionnaire will be written
down phonetically’. The female Moroccan and Turkish
respondents and the interviewers will be matched
according to gender. The interview will take place in the
mother tongue of the participant.
As the target population has a low educational level,
we searched for questionnaires that fit this level. Hence,
we made a selection of existing questionnaires based on
their reliability, validity, and inter-rater reliability among
diverse ethnic populations and people in lower SE
groups. We pretested the Diabetes Problem-Solving
Inventory (DPSI), the Diabetes Social Support Question-
naire DSSQ-Friends Version and DSSQ-Family Version,
the Theory of Planned Behaviour (TpB) Questionnaire,
and the compilation of the Social Capital Question Bank
(see Table 2), and adjusted them to optimally match our
respondents’ ability to answer the questions. We
removed items that our target population did not iden-
tify with (face validity) or that were irrelevant for this
study. Furthermore, a professional adjusted the literacy
level of the questionnaires to the lower educational level
of our target population, and we adapted some items to
make them more culturally sensitive for the different
cultural groups in our study population. For example, in
the DPSI we adjusted some of the vignettes to make
them more appropriate for our different cultural groups.
See Table 2 for an overview of the questionnaires we
used.
Physical examination
The physical examination in the intervention (PTWD)
and comparison group (KYS) will be administered at
T0, T2, and T3, and will consist of a standardized mea-
surement of weight, height, waist and hip circumference,
blood pressure, and heart rate. An anthropometrical
protocol will be used for these measurements. We will
monitor the execution of this procedure.
Blood and urine samples
In the Netherlands, HbA1c levels and fasting plasma
glucose of diabetic patients are measured every three
months. An extensive analysis of blood and urine sam-
ples is performed at least once a year [39]. For T0, T2,
and T3, we will collect these data from the participants’
medical records. More specifically, we will collect:
• Fasting plasma glucose, HbA1c, total cholesterol,
high-density lipoprotein (HDL) cholesterol, triglycer-
ides, creatinine, and creatinine clearance, glomerular
filtration rate calculated according to the Modifica-
tion of Diet in Renal Disease Study (MDRD
equation)
• Microalbuminuria
In addition, we will use medical records to collect
information on the participants’ medication use and dia-
betes-related complications: retinopathy, cataract, kidney
failure, microalbuminuria, myocardial infarction, angina
pectoris, transient ischaemic attack (TIA), cerebrovascu-
lar accident (CVA), claudicatio intermittens, diabetic
ulcers, amputation, polyneuropathy, and sensitivity pro-
blems in the feet.
Qualitative study
We will perform a qualitative study to gain in-depth
understanding of the key mechanisms of PTWD:
changes in the psychosocial mechanisms in the immedi-
ate social environments of the participants. We will
administer semi-structured qualitative interviews with
PTWD and KYS participants. Topics will include overall
experiences with the intervention, perceived changes in
the immediate social environment (psychosocial
mechanisms and social support), and perceived benefits
of the intervention regarding coping skills and DSM.
Process evaluation
The aim of the process evaluation is to gather in-depth
information regarding the fidelity and feasibility of
PTWD and KYS. Data collection will take place during
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the entire intervention period. We will study the jour-
nals and files of the group leaders, in which they will
record the intervention’s implementation and progress.
In addition, we will regularly observe group meetings,
and we will administer a questionnaire and semi-
structured in-depth interviews to the group leaders and
the participants.
Cost-effectiveness
For both PTWD and KYS, we will calculate the organi-
zational costs (e.g. expenses incurred during the
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Figure 1 Measurements in the DISC Study.
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intervention, such as hiring group leaders and locations
and developing intervention materials), non-medical
costs (e.g. expenses incurred by participants because of
their participation in the intervention, such as travel
expenses), and medical costs (e.g. medical expenses
incurred by participants during the intervention, such as
the medication they used and visits to their GPs). We
will also compare these costs with an estimation of the
expenses incurred by the patients in the standard care
group.
Statistical analyses
Assessment of effect
Descriptive statistics will be applied to describe the
study population at baseline. To determine the effect of
the intervention on HbA1c levels and diabetes-related
quality of life and to follow individual change over time,
we will use generalized linear mixed models. Potential
confounders and effect modifiers (e.g. depression, gen-
der, and ethnicity) will be investigated. We will further
examine predictors (including intervention-related pre-
dictors) of a decrease in HbA1c levels and an increase
in diabetes-related quality of life. If necessary, we will
use propensity scores to estimate the effects [51,52].
The level of significance is set at p < 0.05.
The analyses of the qualitative data (semi-structured
in-depth interviews with the participants) will be done
by two researchers using MAXQDA 10, a programme
for qualitative data analysis. We will construct an initial
conceptual framework based on the theoretical assump-
tions of the intervention. The data will be coded accord-
ing to this framework using an inductive approach to
also include other aspects related to the identified
themes and concepts. Next, we will sort and synthesize
the data using thematic charting and further analyse the
data by detecting patterns and developing explanations
[53,54].
Assessment of process
All qualitative data (journals and files of the group lea-
ders, semi-structured in-depth interviews) will be ana-
lysed with MAXQDA according to the principles of
content analysis [53]. The quantitative (semi-structured
questionnaires) data will be analysed with SPSS using
descriptive statistics.
Cost-effectiveness
The costs of the interventions will be described and
compared to the quality-of-life outcome measures.
Discussion
Growing evidence suggests that in addition to social
support, other psychosocial mechanisms in the immedi-
ate social environments of diabetic patients such as
social influence and social engagement have a major
influence on DSM as well. Diabetic patients in lower SE
groups in particular seem to be confronted with strong
psychosocial mechanisms that have an adverse effect on
their DSM and seem to experience more difficulties in
coping with these mechanisms. Therefore, to improve
DSM among these groups it seems necessary to target
all psychosocial mechanisms in the immediate social
environment that impact their DSM: social support,
social influence, and social engagement.
PTWD is, to our knowledge, the first culturally sensi-
tive social network intervention targeted to lower SE
groups that aims to stimulate the long-term social sup-
port of peers and the immediate social environment,
and to target existing psychosocial mechanisms through
which the immediate social environment negatively
influences DSM. The DISC Study evaluates the effective-
ness of PTWD.
A limitation of this study might be that blinding the
GPs during the study was impossible. Another limitation
that might bias the comparability of the groups is that it
was impossible to randomize the intervention and com-
parison groups due to characteristics of the intervention.
We think that the chance of selection bias will be small,
because both the intervention and the comparison
groups will be invited to a lifestyle intervention. We will
record all reasons for participation and non-participa-
tion among our respondents, which will enable us to
assess any selection bias. In addition, we will control for
differences between the groups at baseline and take
these differences into account during the analyses.
The present study will be strengthened by the use of
data triangulation. We will use a wide variety of sources
of information such as questionnaires, semi-structured
qualitative interviews, medical records, physical exami-
nations, and the journals and files of the group leaders.
Table 2 Overview of the questionnaires used in the DISC
Study
Outcome measure Questionnaire
Diabetes-related
quality of life
Diabetes-specific quality-of-life scale [40]
Depression 4DKL (Four-Dimensional Compliant
Questionnaire)
Knowledge SKILLD (spoken knowledge in low literacy in
diabetes scale) [41]
Outcome
expectations
OEDM-P (Outcome Expectations for Diabetes Self-
Management-positive) OEDM-N (Outcome
Expectations for Diabetes Self-Management-
negative) [42]
Self-efficacy Diabetes self-efficacy scale [43,44]
Coping skills DPSI [45]
Social network Compilation from the Social Capital Question
Bank [46,47]
Social support DSSQ-Family Version DSSQ-Friends Version [48,49]
Social influence TpB Questionnaire [50]
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This will increase the validity of this study. Moreover,
the qualitative semi-structured interviews will reveal in-
depth information about lower SE groups that is lacking
to date.
This study will provide insights into how to enable
diabetic patients in lower SE groups to optimally man-
age their diabetes by intervening in the psychosocial
mechanisms in the social environment that negatively
impact their DSM: social support, social influence, and
social engagement. If PTWD is effective in lowering the
HbA1c levels of the participants and improving their
diabetes-related quality of life, further implementation
will be considered. PTWD could be implemented in the
context of a GP practice, where it could contribute to
more efficient diabetes care for diabetic patients in
lower SE groups.
Additional material
Additional file 1: Summary of behavioural goals, determinants
addressed, and strategies used in PTWD phase 1.
Additional file 2: Summary of behavioural goals, determinants
addressed, and strategies used in PTWD phase 2.
Additional file 3: Summary of behavioural goals, determinants
addressed, and strategies used in the meetings for significant
others of PTWD.
Additional file 4: Summary of behavioural goals, determinants
addressed, and strategies used in the social network meetings of
PTWD.
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